Krystal Biotech Inc
(KRYS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,088 | -10,889 | -7,920 | -1,150 | N/A |
| Depreciation Amortization | 1,090 | 141 | 23 | 2 | N/A |
| Accounts payable and accrued liabilities | -199 | 112 | 133 | 42 | N/A |
| Other Working Capital | -1,998 | 511 | 575 | 43 | N/A |
| Other Operating Activity | 1,505 | 680 | 3,299 | -248 | 0 |
| Operating Cash Flow | $-18,690 | $-9,445 | $-3,890 | $-1,311 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,905 | -8,089 | N/A | N/A | N/A |
| PPE Investments | -6,399 | -2,234 | -210 | -15 | N/A |
| Purchase Of Investment | -497 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-4,991 | $-10,323 | $-210 | $-15 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 2,299 | 1,843 | N/A |
| Common Stock Issued | 107,525 | 73,847 | 42,469 | 100 | N/A |
| Other Financing Activity | 0 | 0 | 7,000 | 1,306 | 0 |
| Financing Cash Flow | $107,525 | $73,847 | $51,768 | $3,249 | $N/A |
| Beginning Cash Position | 103,670 | 49,591 | 1,923 | N/A | N/A |
| End Cash Position | 187,514 | 103,670 | 49,591 | 1,923 | N/A |
| Net Cash Flow | $83,844 | $54,079 | $47,668 | $1,923 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,690 | -9,445 | -3,890 | -1,311 | N/A |
| Capital Expenditure | -6,399 | -2,234 | -210 | -15 | N/A |
| Free Cash Flow | -25,089 | -11,679 | -4,100 | -1,326 | 0 |